RESPOND TO PREVENT: Project Description

Community pharmacies are ideally positioned to address the opioid epidemic, as they have a significant amount of face time with both people who have been prescribed opioids and people who access pharmacies for sterile syringes. Pharmacies are expected to provide education to patients on how to safely use and store opioids, minimize opioids risks, and use naloxone.

The RESPOND TO PREVENT training program will address both safe opioid and naloxone dispensing at the pharmacy-level to reduce opioid-related harms for all individuals, regardless of whether they are an illicit drug user or patient receiving opioids for pain management.

Implementation of RESPOND TO PREVENT will occur using a stepped wedge design across five waves: 8 stores per state will be introduced to the intervention every 3 months until all 160 stores have participated. Fidelity checks will ensure consistency. Each store's participation period will last 6 months.

The research team will investigate whether the program positively changes how pharmacists and pharmacy technicians feel about naloxone, how they discuss it with patients and measure how often they prescribe it. The goal is to significantly improve and sustain naloxone distribution and education in pharmacies.


Traci Green, PhD, MSc
Primary Investigator
Brandeis University

Jeffrey Bratberg, PharmD
Co-Investigator & Academic Detailing Lead
University of Rhode Island

Adriane Irwin, PharmD, MS, BCACP, CDE
Co-Investigator & Oregon Academic Detailing Lead
Oregon State University

Dan Hartung, PharmD, MPH
Oregon State University/Oregon Health & Science University

Ryan Hansen, PharmD, PhD
Kelley-Ross Pharmacy Group

Alexander Walley, MD, MSc
Co-Investigator & Subject Matter Expert
Boston University School of Medicine

Caleb Banta-Green, PhD
University of Washington